Tumore del fegato (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Tumore del fegato" in Italian language version.

refsWebsite

Global rank Italian rank

20doi.org

2^nd place

7^th place

20nih.gov

4^th place

9^th place

16oadoi.org

799^th place

22^nd place

2archive.org

6^th place

8^th place

2web.archive.org

1^st place

2cancer.gov

1,684^th place

2,574^th place

1medscape.com

719^th place

799^th place

1ilmessaggero.it

1,738^th place

66^th place

archive.org

World Cancer Report 2014, World Health Organization, 2014, pp. Chapter 1.1, ISBN 92-832-0429-8.
Guan-Cheng Zhao, Y; Qiang, J; Li, C, Q Ju e G. C. Li, Tumor markers for hepatocellular carcinoma (Review), in Molecular and Clinical Oncology, vol. 1, n. 4, 2013, pp. 593–598, DOI:10.3892/mco.2013.119, PMC 3915636, PMID 24649215.

cancer.gov

seer.cancer.gov

SEER Stat Fact Sheets: Liver and Intrahepatic Bile Duct Cancer, su NCI. URL consultato il 18 giugno 2014.

cancer.gov

General Information About Adult Primary Liver Cancer, su cancer.gov, National Cancer Institute. URL consultato il 13 gennaio 2013.

doi.org

dx.doi.org

Collaborators GBD 2013 Mortality and Causes of Death, Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013., in Lancet, 17 dicembre 2014, DOI:10.1016/S0140-6736(14)61682-2, PMID 25530442.
A Jemal, Bray, F, Center, MM, Ferlay, J, Ward, E e Forman, D, Global cancer statistics., in CA: a cancer journal for clinicians, vol. 61, n. 2, Mar–Apr 2011, pp. 69–90, DOI:10.3322/caac.20107, PMID 21296855.
Ahmed, I; Lobo D.N. Ahmed e Dileep N. Lobo, Malignant tumours of the liver, in Surgery (Oxford), vol. 27, n. 1, gennaio 2009, pp. 30–37, DOI:10.1016/j.mpsur.2008.12.005.
S Emre e McKenna, GJ, Liver tumors in children., in Pediatric transplantation, vol. 8, n. 6, dicembre 2004, pp. 632–8, DOI:10.1111/j.1399-3046.2004.00268.x, PMID 15598339.
SA Khan e Davidson, BR; Goldin, RD; Heaton, N; Karani, J; Pereira, SP; Rosenberg, WM; Tait, P; Taylor-Robinson, SD; Thillainayagam, AV; Thomas, HC; Wasan, H; British Society of, Gastroenterology, Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update, in Gut, vol. 61, n. 12, dicembre 2012, pp. 1657–69, DOI:10.1136/gutjnl-2011-301748, PMID 22895392.
A Arzumanyan, Reis, HM e Feitelson, MA, Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma., in Nature reviews. Cancer, vol. 13, n. 2, febbraio 2013, pp. 123–35, DOI:10.1038/nrc3449, PMID 23344543.
HR Rosen, Clinical practice. Chronic hepatitis C infection., in The New England Journal of Medicine, vol. 364, n. 25, 23 giugno 2011, pp. 2429–38, DOI:10.1056/NEJMcp1006613, PMID 21696309.
SW Jeong, Jang, JY e Chung, RT, Hepatitis C virus and hepatocarcinogenesis., in Clinical and molecular hepatology, vol. 18, n. 4, dicembre 2012, pp. 347–56, DOI:10.3350/cmh.2012.18.4.347, PMID 23323249.
S Ralphs e Khan, SA, The role of the hepatitis viruses in cholangiocarcinoma., in Journal of viral hepatitis, vol. 20, n. 5, maggio 2013, pp. 297–305, DOI:10.1111/jvh.12093, PMID 23565610.
MC Kew, Hepatitis viruses (other than hepatitis B and C viruses) as causes of hepatocellular carcinoma: an update., in Journal of viral hepatitis, vol. 20, n. 3, marzo 2013, pp. 149–57, DOI:10.1111/jvh.12043, PMID 23383653.
G Fattovich, Stroffolini, T, Zagni, I e Donato, F, Hepatocellular carcinoma in cirrhosis: incidence and risk factors., in Gastroenterology, vol. 127, 5 Suppl 1, novembre 2004, pp. S35–50, DOI:10.1053/j.gastro.2004.09.014, PMID 15508101.
TW Kensler, Roebuck, BD, Wogan, GN e Groopman, JD, Aflatoxin: a 50-year odyssey of mechanistic and translational toxicology, in Toxicological sciences : an official journal of the Society of Toxicology, 120 Suppl 1, marzo 2011, pp. S28–48, DOI:10.1093/toxsci/kfq283, PMC 3043084, PMID 20881231.
SC Chuang e La Vecchia, C; Boffetta, P, Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection, in Cancer letters, vol. 286, n. 1, 1º dicembre 2009, pp. 9–14, DOI:10.1016/j.canlet.2008.10.040, PMID 19091458.
L Di Tommaso, Sangiovanni, A, Borzio, M, Park, YN, Farinati, F e Roncalli, M, Advanced precancerous lesions in the liver., in Best practice & research. Clinical gastroenterology, vol. 27, n. 2, aprile 2013, pp. 269–84, DOI:10.1016/j.bpg.2013.03.015, PMID 23809245.
N Razumilava e Gores, GJ, Classification, diagnosis, and management of cholangiocarcinoma., in Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, vol. 11, n. 1, gennaio 2013, pp. 13–21.e1; quiz e3–4, DOI:10.1016/j.cgh.2012.09.009, PMID 22982100.
A Davit-Spraul, Gonzales, E, Baussan, C e Jacquemin, E, Progressive familial intrahepatic cholestasis, in Orphanet journal of rare diseases, vol. 4, 8 gennaio 2009, p. 1, DOI:10.1186/1750-1172-4-1, PMC 2647530, PMID 19133130.
MR DeBaun e Tucker, MA, Risk of cancer during the first four years of life in children from The Beckwith-Wiedemann Syndrome Registry., in The Journal of pediatrics, vol. 132, 3 Pt 1, marzo 1998, pp. 398–400, DOI:10.1016/S0022-3476(98)70008-3, PMID 9544889.
LG Spector e Birch, J, The epidemiology of hepatoblastoma., in Pediatric blood & cancer, vol. 59, n. 5, novembre 2012, pp. 776–9, DOI:10.1002/pbc.24215, PMID 22692949.
B Ariff, Lloyd, CR, Khan, S, Shariff, M, Thillainayagam, AV, Bansi, DS, Khan, SA, Taylor-Robinson, SD e Lim, AK, Imaging of liver cancer, in World journal of gastroenterology : WJG, vol. 15, n. 11, 21 marzo 2009, pp. 1289–300, DOI:10.3748/wjg.15.1289, PMC 2658841, PMID 19294758.
Guan-Cheng Zhao, Y; Qiang, J; Li, C, Q Ju e G. C. Li, Tumor markers for hepatocellular carcinoma (Review), in Molecular and Clinical Oncology, vol. 1, n. 4, 2013, pp. 593–598, DOI:10.3892/mco.2013.119, PMC 3915636, PMID 24649215.

ilmessaggero.it

Tumore del fegato, l'esame del colesterolo per individuarlo fino a 5 anni prima: la scoperta in uno studio, su ilmessaggero.it, 17 dicembre 2022. URL consultato il 17 dicembre 2022 (archiviato il 17 dicembre 2022).

medscape.com

emedicine.medscape.com

eMedicine

nih.gov

ncbi.nlm.nih.gov

Collaborators GBD 2013 Mortality and Causes of Death, Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013., in Lancet, 17 dicembre 2014, DOI:10.1016/S0140-6736(14)61682-2, PMID 25530442.
A Jemal, Bray, F, Center, MM, Ferlay, J, Ward, E e Forman, D, Global cancer statistics., in CA: a cancer journal for clinicians, vol. 61, n. 2, Mar–Apr 2011, pp. 69–90, DOI:10.3322/caac.20107, PMID 21296855.
S Emre e McKenna, GJ, Liver tumors in children., in Pediatric transplantation, vol. 8, n. 6, dicembre 2004, pp. 632–8, DOI:10.1111/j.1399-3046.2004.00268.x, PMID 15598339.
SA Khan e Davidson, BR; Goldin, RD; Heaton, N; Karani, J; Pereira, SP; Rosenberg, WM; Tait, P; Taylor-Robinson, SD; Thillainayagam, AV; Thomas, HC; Wasan, H; British Society of, Gastroenterology, Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update, in Gut, vol. 61, n. 12, dicembre 2012, pp. 1657–69, DOI:10.1136/gutjnl-2011-301748, PMID 22895392.
A Arzumanyan, Reis, HM e Feitelson, MA, Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma., in Nature reviews. Cancer, vol. 13, n. 2, febbraio 2013, pp. 123–35, DOI:10.1038/nrc3449, PMID 23344543.
HR Rosen, Clinical practice. Chronic hepatitis C infection., in The New England Journal of Medicine, vol. 364, n. 25, 23 giugno 2011, pp. 2429–38, DOI:10.1056/NEJMcp1006613, PMID 21696309.
SW Jeong, Jang, JY e Chung, RT, Hepatitis C virus and hepatocarcinogenesis., in Clinical and molecular hepatology, vol. 18, n. 4, dicembre 2012, pp. 347–56, DOI:10.3350/cmh.2012.18.4.347, PMID 23323249.
S Ralphs e Khan, SA, The role of the hepatitis viruses in cholangiocarcinoma., in Journal of viral hepatitis, vol. 20, n. 5, maggio 2013, pp. 297–305, DOI:10.1111/jvh.12093, PMID 23565610.
MC Kew, Hepatitis viruses (other than hepatitis B and C viruses) as causes of hepatocellular carcinoma: an update., in Journal of viral hepatitis, vol. 20, n. 3, marzo 2013, pp. 149–57, DOI:10.1111/jvh.12043, PMID 23383653.
G Fattovich, Stroffolini, T, Zagni, I e Donato, F, Hepatocellular carcinoma in cirrhosis: incidence and risk factors., in Gastroenterology, vol. 127, 5 Suppl 1, novembre 2004, pp. S35–50, DOI:10.1053/j.gastro.2004.09.014, PMID 15508101.
TW Kensler, Roebuck, BD, Wogan, GN e Groopman, JD, Aflatoxin: a 50-year odyssey of mechanistic and translational toxicology, in Toxicological sciences : an official journal of the Society of Toxicology, 120 Suppl 1, marzo 2011, pp. S28–48, DOI:10.1093/toxsci/kfq283, PMC 3043084, PMID 20881231.
SC Chuang e La Vecchia, C; Boffetta, P, Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection, in Cancer letters, vol. 286, n. 1, 1º dicembre 2009, pp. 9–14, DOI:10.1016/j.canlet.2008.10.040, PMID 19091458.
L Di Tommaso, Sangiovanni, A, Borzio, M, Park, YN, Farinati, F e Roncalli, M, Advanced precancerous lesions in the liver., in Best practice & research. Clinical gastroenterology, vol. 27, n. 2, aprile 2013, pp. 269–84, DOI:10.1016/j.bpg.2013.03.015, PMID 23809245.
N Razumilava e Gores, GJ, Classification, diagnosis, and management of cholangiocarcinoma., in Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, vol. 11, n. 1, gennaio 2013, pp. 13–21.e1; quiz e3–4, DOI:10.1016/j.cgh.2012.09.009, PMID 22982100.
A Davit-Spraul, Gonzales, E, Baussan, C e Jacquemin, E, Progressive familial intrahepatic cholestasis, in Orphanet journal of rare diseases, vol. 4, 8 gennaio 2009, p. 1, DOI:10.1186/1750-1172-4-1, PMC 2647530, PMID 19133130.
MR DeBaun e Tucker, MA, Risk of cancer during the first four years of life in children from The Beckwith-Wiedemann Syndrome Registry., in The Journal of pediatrics, vol. 132, 3 Pt 1, marzo 1998, pp. 398–400, DOI:10.1016/S0022-3476(98)70008-3, PMID 9544889.
LG Spector e Birch, J, The epidemiology of hepatoblastoma., in Pediatric blood & cancer, vol. 59, n. 5, novembre 2012, pp. 776–9, DOI:10.1002/pbc.24215, PMID 22692949.
B Ariff, Lloyd, CR, Khan, S, Shariff, M, Thillainayagam, AV, Bansi, DS, Khan, SA, Taylor-Robinson, SD e Lim, AK, Imaging of liver cancer, in World journal of gastroenterology : WJG, vol. 15, n. 11, 21 marzo 2009, pp. 1289–300, DOI:10.3748/wjg.15.1289, PMC 2658841, PMID 19294758.
G Malaguarnera, Paladina, I, Giordano, M, Malaguarnera, M, Bertino, G e Berretta, M, Serum markers of intrahepatic cholangiocarcinoma, in Disease markers, vol. 34, n. 4, 2013, pp. 219–28, PMID 23396291.
Guan-Cheng Zhao, Y; Qiang, J; Li, C, Q Ju e G. C. Li, Tumor markers for hepatocellular carcinoma (Review), in Molecular and Clinical Oncology, vol. 1, n. 4, 2013, pp. 593–598, DOI:10.3892/mco.2013.119, PMC 3915636, PMID 24649215.

oadoi.org

Collaborators GBD 2013 Mortality and Causes of Death, Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013., in Lancet, 17 dicembre 2014, DOI:10.1016/S0140-6736(14)61682-2, PMID 25530442.
A Jemal, Bray, F, Center, MM, Ferlay, J, Ward, E e Forman, D, Global cancer statistics., in CA: a cancer journal for clinicians, vol. 61, n. 2, Mar–Apr 2011, pp. 69–90, DOI:10.3322/caac.20107, PMID 21296855.
Ahmed, I; Lobo D.N. Ahmed e Dileep N. Lobo, Malignant tumours of the liver, in Surgery (Oxford), vol. 27, n. 1, gennaio 2009, pp. 30–37, DOI:10.1016/j.mpsur.2008.12.005.
S Emre e McKenna, GJ, Liver tumors in children., in Pediatric transplantation, vol. 8, n. 6, dicembre 2004, pp. 632–8, DOI:10.1111/j.1399-3046.2004.00268.x, PMID 15598339.
SA Khan e Davidson, BR; Goldin, RD; Heaton, N; Karani, J; Pereira, SP; Rosenberg, WM; Tait, P; Taylor-Robinson, SD; Thillainayagam, AV; Thomas, HC; Wasan, H; British Society of, Gastroenterology, Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update, in Gut, vol. 61, n. 12, dicembre 2012, pp. 1657–69, DOI:10.1136/gutjnl-2011-301748, PMID 22895392.
A Arzumanyan, Reis, HM e Feitelson, MA, Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma., in Nature reviews. Cancer, vol. 13, n. 2, febbraio 2013, pp. 123–35, DOI:10.1038/nrc3449, PMID 23344543.
HR Rosen, Clinical practice. Chronic hepatitis C infection., in The New England Journal of Medicine, vol. 364, n. 25, 23 giugno 2011, pp. 2429–38, DOI:10.1056/NEJMcp1006613, PMID 21696309.
SW Jeong, Jang, JY e Chung, RT, Hepatitis C virus and hepatocarcinogenesis., in Clinical and molecular hepatology, vol. 18, n. 4, dicembre 2012, pp. 347–56, DOI:10.3350/cmh.2012.18.4.347, PMID 23323249.
S Ralphs e Khan, SA, The role of the hepatitis viruses in cholangiocarcinoma., in Journal of viral hepatitis, vol. 20, n. 5, maggio 2013, pp. 297–305, DOI:10.1111/jvh.12093, PMID 23565610.
MC Kew, Hepatitis viruses (other than hepatitis B and C viruses) as causes of hepatocellular carcinoma: an update., in Journal of viral hepatitis, vol. 20, n. 3, marzo 2013, pp. 149–57, DOI:10.1111/jvh.12043, PMID 23383653.
G Fattovich, Stroffolini, T, Zagni, I e Donato, F, Hepatocellular carcinoma in cirrhosis: incidence and risk factors., in Gastroenterology, vol. 127, 5 Suppl 1, novembre 2004, pp. S35–50, DOI:10.1053/j.gastro.2004.09.014, PMID 15508101.
SC Chuang e La Vecchia, C; Boffetta, P, Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection, in Cancer letters, vol. 286, n. 1, 1º dicembre 2009, pp. 9–14, DOI:10.1016/j.canlet.2008.10.040, PMID 19091458.
L Di Tommaso, Sangiovanni, A, Borzio, M, Park, YN, Farinati, F e Roncalli, M, Advanced precancerous lesions in the liver., in Best practice & research. Clinical gastroenterology, vol. 27, n. 2, aprile 2013, pp. 269–84, DOI:10.1016/j.bpg.2013.03.015, PMID 23809245.
N Razumilava e Gores, GJ, Classification, diagnosis, and management of cholangiocarcinoma., in Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, vol. 11, n. 1, gennaio 2013, pp. 13–21.e1; quiz e3–4, DOI:10.1016/j.cgh.2012.09.009, PMID 22982100.
MR DeBaun e Tucker, MA, Risk of cancer during the first four years of life in children from The Beckwith-Wiedemann Syndrome Registry., in The Journal of pediatrics, vol. 132, 3 Pt 1, marzo 1998, pp. 398–400, DOI:10.1016/S0022-3476(98)70008-3, PMID 9544889.
LG Spector e Birch, J, The epidemiology of hepatoblastoma., in Pediatric blood & cancer, vol. 59, n. 5, novembre 2012, pp. 776–9, DOI:10.1002/pbc.24215, PMID 22692949.

web.archive.org

Liver tumors | Boston Children's Hospital, su childrenshospital.org. URL consultato l'8 marzo 2015 (archiviato dall'url originale il 4 giugno 2011).
Tumore del fegato, l'esame del colesterolo per individuarlo fino a 5 anni prima: la scoperta in uno studio, su ilmessaggero.it, 17 dicembre 2022. URL consultato il 17 dicembre 2022 (archiviato il 17 dicembre 2022).